Imprivata, which provides authentication and access management technology solutions for the healthcare industry, filed on Monday with the SEC to raise up to $115 million in an initial public offering. The Lexington, MA-based company, which was founded in 2001 and booked $71 million in sales for the year ended December 31, 2013, plans to list on the NYSE under the symbol IMPR. Imprivata initially filed confidentially on January 17, 2014. J.P. Morgan and Piper Jaffray are the joint bookrunners on the deal. No pricing terms were disclosed.
